CD4 and type 1 diabetes mellitus: In another T1DM mouse model induced by low-dose streptozotocin, sitagliptin not only reduced blood glucose level, but also improved inflammation in pancreas by increasing CD4+CD25hiFoxp3+ T cells and reducing inflammatory cells (such as CD11b+ cells and CD4+CD26+ T cells) (164).